Sunshine Biopharma Inc (SBFM)

[Vaison]

I hope you’re correct. I’m certainly still here. I’d like to know what that SEC letter was dated 5/18/22. What were they trying to do? (I’ve copied and pasted the contents of the letter…I can’t seem to attach the letter as a whole)

“This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding any review, comments, action or absence of action by the staff
Please contact Alyssa Wall at 202-551-8106 with any questions.

Sincerely,
Division of Corporation Finance
Office of Trade & Services
CC:
Jeff Cahlon”